Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Mostrar otras versiones (1)

Thalidomide and the immunomodulatory drug, lenalidomide, are therapeutically active in hematological malignancies. The ubiquitously expressed E3 ligase protein cereblon (CRBN) has been identified as the primary teratogenic target of thalidomide. Our studies demonstrate that thalidomide, lenalidomide...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Girona, A, Mendy, D, Ito, T, Miller, K, Gandhi, A K, Kang, J, Karasawa, S, Carmel, G, Jackson, P, Abbasian, M, Mahmoudi, A, Cathers, B, Rychak, E, Gaidarova, S, Chen, R, Schafer, P H, Handa, H, Daniel, T O, Evans, J F, Chopra, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496085/
https://www.ncbi.nlm.nih.gov/pubmed/22552008
http://dx.doi.org/10.1038/leu.2012.119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496085/
https://www.ncbi.nlm.nih.gov/pubmed/22552008
http://dx.doi.org/10.1038/leu.2012.119

Ejemplares similares